Literature DB >> 27393282

Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage.

Ge Tan1, Zilong Hao1, Chunyan Lei1, Yanchao Chen1, Ruozhen Yuan1, Mangmang Xu1, Ming Liu2.   

Abstract

Whether subclinical change of liver function is associated with outcome of spontaneous intracerebral hemorrhage remains to be an open question. A total of 639 patients of spontaneous intracerebral hemorrhage within 7 days from stroke onset were finally enrolled. Liver function indicators, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin (BIL), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGT), albumin (ALB), and international normalized ratio (INR), were collected and collapsed into quartiles. The main outcomes were 30-day death, 90-day death, and 90-day poor outcome (modified Rankin Scale score of 3-6). Two adjusted model, Model 1 and Model 2 (Model 1 plus GCS score), were established to identify independent association between liver function indicators and ICH outcomes. The mortality rate was 19.9 % (127/639) at 30 days and 21.3 % (136/639) at 90 days. Rate of 90-day poor outcome was 51.5 % (329/639). Among liver function indicators, AST and ALP were associated with all the three outcomes, which did not alter significantly when adjusted by Model 1. After adjusted by Model 2, ALP was still associated with outcomes. Association between AST and outcomes was, however, weakened significantly by GCS score. In conclusions, among liver function indicators, AST and ALP were associated with outcomes after spontaneous intracerebral hemorrhage.

Entities:  

Keywords:  Intracerebral hemorrhage; Liver function; Outcome; Risk factor

Mesh:

Substances:

Year:  2016        PMID: 27393282     DOI: 10.1007/s10072-016-2656-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  35 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.

Authors:  Francisco Campos; Tomás Sobrino; Pedro Ramos-Cabrer; Mar Castellanos; Miguel Blanco; Manuel Rodríguez-Yáñez; Joaquín Serena; Rogelio Leira; José Castillo
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-26       Impact factor: 6.200

3.  Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.

Authors:  Francisco Campos; Manuel Rodríguez-Yáñez; Mar Castellanos; Susana Arias; María Pérez-Mato; Tomás Sobrino; Miguel Blanco; Joaquín Serena; José Castillo
Journal:  Clin Sci (Lond)       Date:  2011-07       Impact factor: 6.124

4.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

5.  Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage.

Authors:  Matthew C Loftspring; Holly L Johnson; Rui Feng; Aaron J Johnson; Joseph F Clark
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-24       Impact factor: 6.200

6.  Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian Patients.

Authors:  Baidarbhi Chakraborty; Gaurav Vishnoi; Binita Goswami; Srinivas H Gowda; Debashish Chowdhury; Sarita Agarwal
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-14       Impact factor: 2.136

7.  High serum alkaline phosphatase in relation to cerebral small vessel disease.

Authors:  Wi-Sun Ryu; Seung-Hoon Lee; Chi Kyung Kim; Beom Joon Kim; Hyung-Min Kwon; Byung-Woo Yoon
Journal:  Atherosclerosis       Date:  2013-12-03       Impact factor: 5.162

8.  Spontaneous intracerebral hemorrhage and liver dysfunction.

Authors:  H Niizuma; J Suzuki; T Yonemitsu; T Otsuki
Journal:  Stroke       Date:  1988-07       Impact factor: 7.914

9.  Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004.

Authors:  Todd S Perlstein; Reena L Pande; Mark A Creager; Jennifer Weuve; Joshua A Beckman
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

10.  European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.

Authors:  Thorsten Steiner; Rustam Al-Shahi Salman; Ronnie Beer; Hanne Christensen; Charlotte Cordonnier; Laszlo Csiba; Michael Forsting; Sagi Harnof; Catharina J M Klijn; Derk Krieger; A David Mendelow; Carlos Molina; Joan Montaner; Karsten Overgaard; Jesper Petersson; Risto O Roine; Erich Schmutzhard; Karsten Schwerdtfeger; Christian Stapf; Turgut Tatlisumak; Brenda M Thomas; Danilo Toni; Andreas Unterberg; Markus Wagner
Journal:  Int J Stroke       Date:  2014-08-24       Impact factor: 5.266

View more
  8 in total

1.  The predictive accuracy of the black hole sign and the spot sign for hematoma expansion in patients with spontaneous intracerebral hemorrhage.

Authors:  Zhiyuan Yu; Jun Zheng; Lu Ma; Rui Guo; Mou Li; Xiaoze Wang; Sen Lin; Hao Li; Chao You
Journal:  Neurol Sci       Date:  2017-06-02       Impact factor: 3.307

2.  BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation.

Authors:  Y Yu; L Hu; X Huang; W Zhou; H Bao; X Cheng
Journal:  J Endocrinol Invest       Date:  2020-05-13       Impact factor: 4.256

3.  Moderate-Severe White Matter Lesion Predicts Delayed Intraventricular Hemorrhage in Intracerebral Hemorrhage.

Authors:  Mengying Yu; Dongqin Zhu; Zhixian Luo; Zhifang Pan; Yunjun Yang; Haoli Xu
Journal:  Neurocrit Care       Date:  2022-07-07       Impact factor: 3.210

Review 4.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

5.  Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.

Authors:  Neal S Parikh; Hooman Kamel; Babak B Navi; Costantino Iadecola; Alexander E Merkler; Arun Jesudian; Jesse Dawson; Guido J Falcone; Kevin N Sheth; David J Roh; Mitchell S V Elkind; Daniel F Hanley; Wendy C Ziai; Santosh B Murthy
Journal:  Stroke       Date:  2020-01-07       Impact factor: 7.914

6.  Treatment of Naoxueshu Promotes Improvement of Hematoma Absorption and Neurological Function in Acute Intracerebral Hemorrhage Patients.

Authors:  Juexian Song; Yi Lyu; Pingping Wang; Yuting Nie; Huiqiang Lu; Li Gao; Xiaolin Tong
Journal:  Front Physiol       Date:  2018-07-20       Impact factor: 4.566

7.  Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage.

Authors:  Huan Wang; Jiongxing Wu; Xue Yang; Junfeng Liu; Wendan Tao; Zilong Hao; Bo Wu; Ming Liu; Shihong Zhang; Deren Wang
Journal:  BMC Neurol       Date:  2021-12-09       Impact factor: 2.474

Review 8.  TNAP as a therapeutic target for cardiovascular calcification: a discussion of its pleiotropic functions in the body.

Authors:  Claudia Goettsch; Agnieszka Strzelecka-Kiliszek; Laurence Bessueille; Thibaut Quillard; Laura Mechtouff; Slawomir Pikula; Emmanuelle Canet-Soulas; Jose Luis Millan; Caroline Fonta; David Magne
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.